Insights gained into the injury mechanism of drug and herb induced liver injury in the hepatic microenvironment
Authors:
- 29 July 2024
- journal article
- research article
- Published by Elsevier in Toxicology
- Vol. 507, 153900
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 135 references indexed in Scilit:
- ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liverHepatology, 2022
- A revised electronic version of RUCAM for the diagnosis of DILIHepatology, 2022
- Curcumin attenuates isoniazid‐induced hepatotoxicity by upregulating the SIRT1/PGC‐1α/NRF1 pathwayJournal of Applied Toxicology, 2022
- Roles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity2019
- Protective role of c‐Jun N‐terminal kinase‐2 (JNK2) in ibuprofen‐induced acute liver injuryThe Journal of Pathology, 2018
- Drug‐induced cholestasisHepatology Communications, 2017
- Establishment of a mouse model for amiodarone‐induced liver injury and analyses of its hepatotoxic mechanismJournal of Applied Toxicology, 2015
- T‐helper cell‐mediated factors in drug‐induced liver injuryJournal of Applied Toxicology, 2015
- Drug-induced cholestasisHepatology, 2011
- Natural killer cells become tolerogenic after interaction with apoptotic cellsEuropean Journal of Immunology, 2010